首页> 美国卫生研究院文献>Journal of Atherosclerosis and Thrombosis >A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient
【2h】

A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient

机译:脂肪酶成熟因子1的复合杂合突变负责患者的高甘油三酯血症。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Aim: Dyslipidemia is the most common lipid metabolism disorder in humans, and its etiology remains elusive. Hypertriglyceridemia (HTG) is a type of dyslipidemia that contributes to atherosclerosis and coronary heart disease. Previous studies have demonstrated that mutations in lipoprotein lipase (LPL), apolipoprotein CII (APOC2), apolipoprotein AV (APOA5), glycosylphosphatidylinositol anchored high-density lipoprotein-binding protein 1 (GPIHBP1), lipase maturation factor 1 (LMF1), and glycerol-3 phosphate dehydrogenase 1 (GPD1) are responsible for HTG by using genomic microarrays and next-generation sequencing. The aim of this study was to identify genetic lesions in patients with HTG.>Method: Our study included a family of seven members from Jiangsu province across three generations. The proband was diagnosed with severe HTG, with a plasma triglyceride level of 38.70 mmol/L. Polymerase chain reaction (PCR) and Sanger sequencing were performed to explore the possible causative gene mutations for this patient. Furthermore, we measured the post-heparin LPL and hepatic lipase (HL) activities using an antiserum inhibition method.>Results: A compound heterozygous mutation in the LMF1 gene (c.257C > T/p.P86L and c.1184C > T/p. T395I) was identified and co-segregated with the affected patient in this family. Both mutations were predicted to be deleterious by three bioinformatics programs (Polymorphism Phenotyping-2, Sorting Intolerant From Tolerant, and MutationTaster). The levels of the plasma post-heparin LPL and HL activities in the proband (57 and 177 mU/mL) were reduced to 24% and 75%, respectively, compared with those assayed in the control subject with normal plasma triglycerides.>Conclusion: A compound heterozygous mutation of LMF1 was identified in the presenting patient with severe HTG. These findings expand on the spectrum of LMF1 mutations and contribute to the genetic diagnosis and counseling of families with HTG.
机译:>目的:血脂异常是人类最常见的脂质代谢异常,其病因仍然难以捉摸。高甘油三酯血症(HTG)是一种血脂异常,导致动脉粥样硬化和冠心病。先前的研究表明,脂蛋白脂肪酶(LPL),载脂蛋白CII(APOC2),载脂蛋白AV(APOA5),糖基磷脂酰肌醇固定的高密度脂蛋白结合蛋白1(GPIHBP1),脂肪酶成熟因子1(LMF1)和甘油- 3磷酸脱氢酶1(GPD1)通过使用基因组微阵列和下一代测序来负责HTG。这项研究的目的是鉴定HTG患者的遗传病变。>方法:我们的研究包括来自江苏省的7个成员,分三代。先证者被诊断出患有严重的HTG,血浆甘油三酸酯水平为38.70 mmol / L。进行了聚合酶链反应(PCR)和Sanger测序,以探讨该患者可能的致病基因突变。此外,我们使用抗血清抑制方法测量了肝素后LPL和肝脂肪酶(HL)的活性。>结果:LMF1基因中有一个复合杂合突变(c.257C> T / p.P86L和确定了c.1184C> T / p。T395I)并与该家庭中的受影响患者共隔离。通过三个生物信息学程序(多态性表型2,从耐受中分选不耐受和MutationTaster)预测这两个突变都是有害的。与使用正常血浆甘油三酸酯的对照组相比,先证者的血浆肝素LPL和HL活性水平(分别为57和177 mU / mL)分别降低至24%和75%。>结论:在重度HTG患者中发现了LMF1的复合杂合突变。这些发现扩大了LMF1突变的范围,并有助于HTG家庭的遗传诊断和咨询。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号